Movement Alert｜Thermo Fisher Scientific Rises 3.52% in Regular Trading, Life Sciences Sector Rallies as CDMO Partnership Expands

Market Focus06-25 22:10

On June 25, Thermo Fisher Scientific rose 3.52% in regular trading, trading at approximately $511.09 per share, with turnover of $187 million, extending gains from the prior session.

On the news front, the Life Sciences Tools & Services sector rallied broadly, while Thermo Fisher recently secured a CDMO partnership with Nuvation Bio to manufacture the anti-cancer drug IBTROZI (taletrectinib) in the United States through its Patheon pharmaceutical services platform. Nuvation Bio completed a technology transfer and product introduction to Thermo Fisher for the production of the ROS1-positive non-small cell lung cancer therapy, with the supplemental filing to the NDA already completed. The collaboration demonstrates Thermo Fisher's expanding contract manufacturing capabilities for innovative oncology therapies.

Within the Life Sciences Tools & Services sector, Bio-Techne surged 19.39%, Tempus AI gained 4.41%, Danaher rose 3.71%, West Pharmaceutical added 2.63%, and IQVIA climbed 2.52%, reflecting broad-based sector strength.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1124702490?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-25 22:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124702490","market":"us","top_or_hot":-1,"title":"Movement Alert｜Thermo Fisher Scientific Rises 3.52% in Regular Trading, Life Sciences Sector Rallies as CDMO Partnership Expands","media":"Market Focus","content":"<p><p>On June 25, Thermo Fisher Scientific rose 3.52% in regular trading, trading at approximately $511.09 per share, with turnover of $187 million, extending gains from the prior session.</p><p>On the news front, the Life Sciences Tools & Services sector rallied broadly, while Thermo Fisher recently secured a CDMO partnership with Nuvation Bio to manufacture the anti-cancer drug IBTROZI (taletrectinib) in the United States through its Patheon pharmaceutical services platform. Nuvation Bio completed a technology transfer and product introduction to Thermo Fisher for the production of the ROS1-positive non-small cell lung cancer therapy, with the supplemental filing to the NDA already completed. The collaboration demonstrates Thermo Fisher's expanding contract manufacturing capabilities for innovative oncology therapies.</p><p>Within the Life Sciences Tools & Services sector, Bio-Techne surged 19.39%, Tempus AI gained 4.41%, Danaher rose 3.71%, West Pharmaceutical added 2.63%, and IQVIA climbed 2.52%, reflecting broad-based sector strength.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Thermo Fisher Scientific Rises 3.52% in Regular Trading, Life Sciences Sector Rallies as CDMO Partnership Expands</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Thermo Fisher Scientific Rises 3.52% in Regular Trading, Life Sciences Sector Rallies as CDMO Partnership Expands\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-25 22:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 25, Thermo Fisher Scientific rose 3.52% in regular trading, trading at approximately $511.09 per share, with turnover of $187 million, extending gains from the prior session.</p><p>On the news front, the Life Sciences Tools & Services sector rallied broadly, while Thermo Fisher recently secured a CDMO partnership with Nuvation Bio to manufacture the anti-cancer drug IBTROZI (taletrectinib) in the United States through its Patheon pharmaceutical services platform. Nuvation Bio completed a technology transfer and product introduction to Thermo Fisher for the production of the ROS1-positive non-small cell lung cancer therapy, with the supplemental filing to the NDA already completed. The collaboration demonstrates Thermo Fisher's expanding contract manufacturing capabilities for innovative oncology therapies.</p><p>Within the Life Sciences Tools & Services sector, Bio-Techne surged 19.39%, Tempus AI gained 4.41%, Danaher rose 3.71%, West Pharmaceutical added 2.63%, and IQVIA climbed 2.52%, reflecting broad-based sector strength.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TMO","symbol_name":"赛默飞世尔","start_time":0,"source_url":"","article_id":"1124702490","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124702490","pubTimestamp":1782396632,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 25, Thermo Fisher Scientific rose 3.52% in regular trading, trading at approximately $511.09 per share, with turnover of $187 million, extending gains from the prior session.On the news...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TMO":"赛默飞世尔"},"translate_title":"动向提示|赛默飞世尔科技常规交易涨3.52%CDMO合作关系扩大生命科学板块反弹","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TMO":1},"content_text":"On June 25, Thermo Fisher Scientific rose 3.52% in regular trading, trading at approximately $511.09 per share, with turnover of $187 million, extending gains from the prior session.On the news front, the Life Sciences Tools & Services sector rallied broadly, while Thermo Fisher recently secured a CDMO partnership with Nuvation Bio to manufacture the anti-cancer drug IBTROZI (taletrectinib) in the United States through its Patheon pharmaceutical services platform. Nuvation Bio completed a technology transfer and product introduction to Thermo Fisher for the production of the ROS1-positive non-small cell lung cancer therapy, with the supplemental filing to the NDA already completed. The collaboration demonstrates Thermo Fisher's expanding contract manufacturing capabilities for innovative oncology therapies.Within the Life Sciences Tools & Services sector, Bio-Techne surged 19.39%, Tempus AI gained 4.41%, Danaher rose 3.71%, West Pharmaceutical added 2.63%, and IQVIA climbed 2.52%, reflecting broad-based sector strength.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1124702490","isCrawlerRequest":true}